Jahreskongress
Congrès Annuel
Annual Meeting
Interlaken
Congress Centre Kursaal Interlaken
12.-13.September 2019
Menu
Programme
Thursday, 12.9.2019
| 0830-1000 Theatersaal | IBD Treatment 2019 (sponsered by MSD) Stephan Brand, St. Gallen Gerhard Rogler, Zürich |
| 0830-0900 Theatersaal | The role of Vedolizumab in real life IBD treatment Frank Seibold, Bern |
| 0900-0930 Theatersaal | JAK Inhibitors: Benefits and risks in ulcerative colitis patients Pierre Michetti, Lausanne |
| 0930-1000 Theatersaal | Which drug to choose: Evidence based treatment decisions in a landscape of growing option Britta Siegmund, Berlin |
| 0830-1000 Kongresssaal | New Challenges in Hepatology Andrea De Gottardi, Bern Christine Bernsmeier, Basel |
| 0830-0845 Kongresssaal | Immunotherapy and HCC Markus Heim, Basel |
| 0845-0900 Kongresssaal | Primary Sclerosing Cholangitis and cholangiocarcinoma surveillance Joachim Mertens, Zürich |
| 0900-0915 Kongresssaal | Cirrhosis - a temporary disease? Annalisa Berzigotti, Bern |
| 0915-0930 Kongresssaal | Acute alcoholic hepatitis: who to transplant? Laurent Spahr, Genève |
| 0930-0945 Kongresssaal | Hepatitis B - to stop or not to stop therapy? Darius Moradpour, Lausanne |
| 0945-1000 Kongresssaal | New therapies for NASH Nicolas Goossens, Genève |
| 0830-1000 Saal Brünig | SGVC: Peritonitis and Abdominal Sepsis Markus K. Müller, Frauenfeld Dieter Hahnloser, Lausanne |
| 0830-0855 Saal Brünig | Damage Control Surgery in Peritonitis Martin Bolli, Basel |
| 0855-0920 Saal Brünig | „Just for the sofa? The Value of Scores in Abdominal Sepsis“ Daniel M. Frey, Wetzikon |
| 0920-1000 Saal Brünig | Antibiotic Treatment of Peritonitis Christian Eckmann, Peine |
| 1000-1030 Exhibition Area | Coffee break |
| 1030-1200 Theatersaal | SGG-SGVC-Joint Session (sponsered by Takeda Pharma AG): Prize winner / surgery in cirrhotic patients Peter Bauerfeind, Zürich Beat Müllhaupt, Zürich Jean-Louis Frossard, Genève Antonio Nocito, Baden |
| 1030-1050 Theatersaal | Prizewinners |
| 1030-1040 Theatersaal | Gastroenterology Prize Talk: Microbial network disturbances in relapsing refractory Crohn’s disease Bahtiyar Yilmaz, Bern |
| 1040-1050 Theatersaal | Hepatology Prize Talk: Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver Aleksei Suslov, Basel |
| 1050-1100 Theatersaal | Surgery Prize Talk: Does Coffee Intake Reduce Postoperative Ileus After Laparoscopic Elective Colorectal Surgery? Simone Hasler-Gehrer, Baden |
| 1050-1110 Theatersaal | Surgery in Cirrhotic Patients: Risk stratification and presurgical considerations David Semela, St. Gallen |
| 1110-1130 Theatersaal | General surgery in cirrhotic patients Guido Beldi, Bern |
| 1130-1150 Theatersaal | Hepatic surgery in cirrhotic patients Christian Toso, Genève |
| 1200-1230 Exhibition Area | Lunch break |
| 1230-1315 Theatersaal | Lunch Symposium Pfizer: Xeljanz® (Tofacitinib): A practical guide to JAK Inhibition in UC |
| 1230-1315 Kongresssaal | Lunch Symposium Janssen-Cilag AG: Learning biological use in CD from international experts |
| 1230-1315 Saal Brünig | Lunch Symposium Takeda Pharma AG: Comparative Evidence in Ulcerative Colitis - the VARSITY Study: Vedolizumab vs Adalimumab |
| 1230-1315 Saal Harder | Lunch Symposium AbbVie: Hepatitis C Elimination by 2030. Gastroenterologists Evolving Role |
| 1330-1500 Theatersaal | IBD: Fistula therapy and free communications Pierre Michetti, Lausanne Andrew Macpherson, Bern |
| 1330-1340 Theatersaal | Isoproterenol activates gut-liver-axis: effects on intestinal mucus and vascular barrier as entry sites Marcel Sorribas, Bern |
| 1340-1350 Theatersaal | The intra-individual Variability of Fecal Calprotectin in patients with GI-symptoms Seraina Netzer, Bern |
| 1350-1400 Theatersaal | Obesity is frequent in inflammatory bowel disease patients and associated with higher disease activity in Crohn's disease, but not ulcerative colitis Thomas Greuter, Zürich |
| 1400-1410 Theatersaal | Efficacy of Etrolizumab in patients with moderate to severe UC who had failed TNF Antagonist Therapy (HICKORY) Frank Seibold, Bern |
| 1410-1420 Theatersaal | LPA-induced GPR35 signaling in macrophages resulted in reduced TNF production associated with decreased intestinal corticosterone synthesis Berna Kaya, Basel |
| 1420-1430 Theatersaal | Is IBDialog monthly a helpful tool in daily clinical practice? Lisa Schmitz, Wattwil |
| 1430-1500 Theatersaal | Fistula therapy with mesenchymal stem cells: First experiences and perspectives: case presentations Alain Schoepfer, Lausanne Luc Biedermann, Zürich Matthias Turina, Zürich |
| 1330-1500 Kongresssaal | Hereditary colon cancer syndroms and free communications Dieter Hahnloser, Lausanne Reiner Wiest, Bern |
| 1330-1400 Kongresssaal | Hereditary colon cancer syndroms Gabriela Möslein, Wuppertal |
| 1400-1410 Kongresssaal | Aspirin suppresses age-associated and colon cancer relevant DNA methylation changes in the healthy colon Faiza Noreen, Basel |
| 1410-1420 Kongresssaal | Liver fibrosis screening in patients undergoing a screening colonoscopy (FIB-SCREEN): feasibility and preliminary results of a prospective study Yves Flattet, Genève |
| 1420-1430 Kongresssaal | Drug-induced liver toxicity in a prospective cohort of cancer patients receiving immune checkpoint inhibitors Lukas Flatz, St. Gallen |
| 1430-1440 Kongresssaal | Endoscopic full-thickness resection for early colorectal cancer Patrick Aepli, Luzern |
| 1440-1450 Kongresssaal | Pain after FTRD in the upper and lower GI tract –a single center experience Henriette Heinrich, Zürich |
| 1450-1500 Kongresssaal | Beta6-Integrin – A novel Serum Marker predicting overall Survival in Pancreatic Adenocarcinoma Bernhard Morell, Zürich |
| 1330-1500 Saal Brünig | SGVC: Endocrine Surgery Frédéric Triponez, Genève Stefan Wildi, Zürich |
| 1330-1350 Saal Brünig | Malignant Thyroid Neoplasms Reto Kaderli, Bern |
| 1350-1410 Saal Brünig | Benign Thyroid Diseases Thomas Clerici, St. Gallen |
| 1410-1430 Saal Brünig | Diseases of the Parathyroid Gland Diana Vetter, Zürich |
| 1430-1450 Saal Brünig | Complications in Thyroid and Parathyroid Surgery Frédéric Triponez, Genève |
| 1500-1530 Exhibition Area | Coffee break |
| 1530-1700 Theatersaal | Endoscopy and free communications Lukas Degen, Basel Robert Bründler, Luzern Magnus Paul Schneider, Zürich |
| 1530-1540 Theatersaal | Eosinophilic esophagitis-like disease with lack of significant esophageal eosinophilia: Description of a new disease entity Thomas Greuter, Zürich |
| 1540-1550 Theatersaal | IL-20 cytokine signaling modulates eosinophilic esophagitis Tanay Kaymak, Basel |
| 1550-1600 Theatersaal | Endoscopic Vacuum Therapy by EsoSponge® : treatment of oesogastroduodenal leakage. Who‘s the best patient? Philippe Bichard, Genève |
| 1600-1610 Theatersaal | Endoscopic Ultrasound-guided Radiofrequency Ablation for Pancreatic Neuroendocrine Tumors: a retrospective single center study Toni Trosic-Ivanisevic, Lausanne |
| 1610-1620 Theatersaal | Five-year audit of endoscopic submucosal dissection (ESD) in daily clinical practice Dominik Pytlik, Bern |
| 1620-1630 Theatersaal | Feasibility of ileal intubation in colonoscopy with Endocuff: a prospective open label comparison Mikael Sawatzki, St. Gallen |
| 1630-1700 Theatersaal | Fundoplication and bariatric surgery: when does endoscopy replace surgery? Thomas Rösch, Hamburg |
| 1530-1700 Kongresssaal | Neurogastroenterology and free communications Radu Tutuian, Solothurn Joachim Mertens, Zürich Daniel Pohl, Zürich |
| 1530-1600 Kongresssaal | What to do after negative diagnostic procedures Frank Zerbib, Bordeaux |
| 1600-1610 Kongresssaal | Clinical outcome after single EsoFLIP dilation in patients with achalasia Fritz Murray, Zürich |
| 1610-1620 Kongresssaal | Functional Luminal Imaging Probe (EndoFLIP®) unveils endoscopically non-visible esophageal strictures in dysphagia patients Ioannis Linas, Bern |
| 1620-1630 Kongresssaal | A Specific Subtype of Hepatitis E Virus Circulates Widely in Switzerland Jérôme Gouttenoire, Lausanne |
| 1630-1640 Kongresssaal | Liver function assessment by 13C-methacetin test before and after placement of a transjugular portosystemic shunt: A prospective pilot study David Semela, St. Gallen |
| 1640-1650 Kongresssaal | Real-World Effectiveness and Safety of Glecaprevir plus Pibrentasvir in HCV: Postmarketing Observational Data from Switzerland Nasser Semmo, Bern |
| 1650-1700 Kongresssaal | Large-scale screening is not useful to identify individuals with hepatitis B or C virus infection: Final results of a Swiss prospective study Aicha Trabelsi, Lausanne |
| 1530-1700 Saal Brünig | SGVC: Parietology Diego De Lorenzi, Grabs Franc Hetzer, Uznach |
| 1530-1550 Saal Brünig | TIPP, TAPP, TEP what else? Christian Helbling, Uznach |
| 1550-1610 Saal Brünig | Open Repair of Incisional Hernia Dominique Sülberg, Baden |
| 1610-1630 Saal Brünig | Minimally Invasive Repair of Incisional Hernia Ulrich Dietz, Solothurn |
| 1630-1650 Saal Brünig | Complications after Hernia Repair Markus Schäfer, Lausanne |
| 1715-1815 Theatersaal | GA SGGSSG |
| 1815-1900 Theatersaal | GA SASL |
| 1815-1900 Kongresssaal | GA MDL |
| 1815-1900 Saal Brünig | GA IBDNet |
| 1815-1900 Saal Harder | GA SwissNGM |
Friday, 13.9.2019
| 0830-1000 Theatersaal | Gastroenterology: Rapid Fire Answers to hot topics Sébastien Godat, Lausanne Christoph Gubler, Zürich Carlo Valli, Visp |
| 0830-0845 Theatersaal | Bile duct stone: papillotomy, balloon or both? Jean-Louis Frossard, Genève |
| 0845-0900 Theatersaal | Antithrombotic agents and polypectomy: news? Nico Wiegand, Luzern |
| 0900-0915 Theatersaal | Colon polyp in the old patient: resection, biopsy, watch and wait? Kaspar Truninger, Langenthal |
| 0915-0930 Theatersaal | Eosinophilic esophagitis: treatment strategy Alain Schoepfer, Lausanne |
| 0930-0945 Theatersaal | How to perform balloon dilatation in Achalasia? Radu Tutuian, Solothurn |
| 0945-1000 Theatersaal | How to identify IM in the stomach and follow-up Jan Borovicka, St.Gallen |
| 0830-1000 Kongresssaal | SASL Hot Topics: Hepatitis D, NAFLD and TIPPS Andrea De Gottardi, Bern Francesco Negro, Genève |
| 0830-0900 Kongresssaal | Hepatitis D: unsolved issues Mario Rizzetto, Torino |
| 0900-0930 Kongresssaal | NAFLD-HCC: specificities in diagnosis and management Jean-François Dufour, Bern |
| 0930-1000 Kongresssaal | Early/preemptive TIPPS in patients with cirrhosis and variceal bleeding Juan Carlos Garcia-Pagán, Barcelona |
| 0830-1000 Saal Brünig | SGVC free communications Frédéric Ris, Genève Bruno Schmied, St. Gallen |
| 0830-0840 Saal Brünig | Assessment of radiological rectal cancer restaging after chemoradiotherapy Andreas Kohler, Bern |
| 0840-0850 Saal Brünig | Meta-analysis of randomized controlled trials of surgery for rectal cancer Georgios Peros, Winterthur |
| 0850-0900 Saal Brünig | Survival after hepatectomy for colorectal liver metastases is a function of intrahepatic recurrence but is not dependent of recurrence at the liver resection margin: a bicentric experience Andreas Andreou, Bern |
| 0900-0910 Saal Brünig | Single cell RNA-seq Atlas of a Regenerating Liver in Mice Daniel Sánchez-Taltavull, Bern |
| 0910-0920 Saal Brünig | Minimal-Invasive Versus Open Hepatectomy for Colorectal Liver Metastases: Bicentric Analysis of Postoperative Outcomes and Long-Term Survival Using Propensity Score Matching Analysis Andreas Andreou, Bern |
| 0920-0930 Saal Brünig | Inherited polymorphic p53 response elements in the human genome interact with somatic p53 mutations to affect patient survival: a pan-cancer analysis Lukasz Filip Grochola, Winterthur |
| 0930-0940 Saal Brünig | Minimal length of proximal resection margin in adenocarcinoma of the esophagogastric junction: a systematic review of the literature Nadja Niclauss, Genève |
| 0940-0950 Saal Brünig | 4 years experience of robotic-assisted (da Vinci Xi) giant hiatal hernia repair: feasibility, quality and comparison to the standard laparoscopic approach Alexander Wilhelm, Basel |
| 0950-1000 Saal Brünig | Laparoscopic surgery for gastric cancer: the European point of view Mickael Chevalley, Genève |
| 1000-1030 Exhibition Area | Coffee break |
| 1030-1200 Theatersaal | SGG-SGVC-GESKES Joint Session: Nutrition for everybody Andrew Macpherson, Bern Rémy Meier, Liestal Ralph Peterli, Basel |
| 1030-1050 Theatersaal | Microbiom and stool transplantation Herbert Tilg, Innsbruck |
| 1050-1110 Theatersaal | Monitoring of Nutrition in patients with impaired resorption Reinhard Imoberdorf, Winterthur |
| 1110-1130 Theatersaal | Low Fodmap diet- past hype, still hope? Claudia Krieger-Grübel, St. Gallen |
| 1130-1150 Theatersaal | Nutrition in liver cirrhosis (ESPEN/EASL Guidelines) Laurence Genton, Genève |
| 1200-1230 Exhibition Area | Lunch break |
| 1230-1315 Theatersaal | Lunch Symposium AbbVie: Improve your skills in IBD management: Case-based discussions |
| 1230-1315 Kongresssaal | Lunch Symposium Vifor Pharma Suisse: The Gastro Cruise: Zürich-New York direct/Panama strait/Welcome to the jungle |
| 1230-1315 Saal Brünig | Lunch Symposium Norgine AG: NEW ALLY IN COLON CANCER PREVENTION? |
| 1230-1315 Saal Harder | Lunch Symposium Takeda Pharma AG: The future is now - Innovative Surgical Procedures for the treatment of perianal fistula in Crohn's Disease |
| 1330-1500 Theatersaal | Endoscopy Video session: How I do it Sébastien Godat, Lausanne Reiner Wiest, Bern |
| 1330-1500 Theatersaal | Video Session Polypectomy Lukas Degen, Basel Patrick Aepli, Luzern Gian Dorta, Lausanne Hans-Dieter Allescher, Garmisch-Partenkirchen |
| 1330-1500 Kongresssaal | GESKES Session: Nutrition, Resorption and Perception Peter Ballmer, Winterthur Claudia Heidegger, Genève |
| 1330-1350 Kongresssaal | Proteins for the surgical patient Martin Hübner, Lausanne |
| 1350-1410 Kongresssaal | Effort Study update Philipp Schütz, Aarau |
| 1410-1430 Kongresssaal | Pharmacology: Resorption of drugs in postoperative patients Markus Lampert, Solothurn |
| 1430-1450 Kongresssaal | Food image understanding: How close can we get? Zeno Stanga, Bern |
| 1330-1500 Saal Brünig | SGVC: Rapid Fire Answers to hot topics Pietro Majno-Hurst, Lugano Carsten Thomas Viehl, Biel-Bienne |
| 1330-1340 Saal Brünig | Ta TME or Robotic which way to go to the Rectum Nicolas Buchs, Genève |
| 1340-1350 Saal Brünig | Treatment of Mucinous Neoplasms of the Appendix Kuno Lehmann, Zürich |
| 1350-1400 Saal Brünig | Sense or Nonsense of Laparoscopic Whipple Procedure: Pro Stefan Breitenstein, Winterthur |
| 1400-1410 Saal Brünig | Sense or Nonsense of Laparoscopic Whipple Procedure: Contra Nermin Halkic, Lausanne |
| 1410-1420 Saal Brünig | Treatment of GERD: New Tools for an old Disease? Yves Borbély, Bern |
| 1420-1430 Saal Brünig | Modern treatment of Anal Fistula Dimitri Christoforidis, Lugano |
| 1430-1440 Saal Brünig | HIPEC, PIPAC or Cytoreductive Surgery alone Martin Hübner, Lausanne |
| 1500-1530 Exhibition Area | Coffee break |
| 1530-1700 Theatersaal | SGG-SGVC Joint Session: Grande Finale Peter Bauerfeind, Zürich Markus Weber, Zürich |
| 1530-1550 Theatersaal | Pancreas Cancer: new diagnostic tools, surveillance of patients at risk Julia Mayerle, München |
| 1550-1600 Theatersaal | Discussion Daniel Candinas, Bern |
| 1600-1620 Theatersaal | Endoscopic resection of early cancer: strategy in patients with high risk histology Alexander Meining, Ulm |
| 1620-1630 Theatersaal | Discussion Markus von Flüe, Basel |
| 1630-1650 Theatersaal | Endoscopic therapy of functional disorders Horst Neuhaus, Düsseldorf |
| 1650-1700 Theatersaal | Discussion Magnus Paul Schneider, Zürich |
| 1530-1700 Saal Brünig | GESKES: Abschlussvorträge des ZKE Lehrganges Reinhard Imoberdorf, Winterthur Andrea Kopp-Lugli, Basel |
| 1715-1800 Saal Brünig | GA GESKES |
Posters
Gastroenterology
| G1 | Diaphragm Disease im Colon ascendens ohne Einnahme von nichtsteroidalen Antirheumatika – ein Fallbericht Robert Bauer (1) Urs Pfefferkorn(2) (1) Chirurgische Klinik, Kantonsspital Baselland, Liestal (2) Chirurgische Klinik, Solothurner Spitäler AG, Olten | |
| G2 | Feasibility of cecal retroflexion in screening colonoscopy with Endocuff Mikael Sawatzki (1), Jan Borovicka (1), Stephan Baumeler (1) 1 Division of Gastroenterology/ Hepatology, Kantonsspital St. Gallen, Switzerland | |
| G3 | A rare case of gastric outlet obstruction in a patient with multiple myeloma Rahel Haeuptle (1), Christoph Driessen (2), Jan Borovicka(1), Mikael Sawatzki (1) 1 Division of Gastroenterology, Kantonsspital St.Gallen, Switzerland 2 Division of Oncolocy, Kantonsspital St.Gallen, Switzerland | |
| G4 | “Spontaneous” bowel perforation caused by oral preparation for colonoscopy Mikael Sawatzki (1), Samuel Henz (2), Rebecca Schiefer (2), Roland Hausmann (3), Jan Borovicka (1) 1 Division of Gastroenterology, Kantonsspital St. Gallen, Switzerland 2 Department of Internal Medicine, Spital Rorschach, Switzerland 3 Institute of Legal Medicine, Kantonsspital St. Gallen, Switzerland | |
| G5 | The intra-individual Variability of Fecal Calprotectin in healthy individuals Seraina Netzer Peter Netzer Gastrozentrum Netzer AG, Bremgartenstrasse 115, 3012 Bern Lindenhofspital Bern, Bremgartenstrasse 117, 3001 Bern | |
| G6 | Audit of colon polyps’ surveillance programme in daily clinical practice Seraina Netzer Peter Netzer Gastrozentrum Netzer AG, Bremgartenstrasse 115, 3012 Bern Lindenhofspital Bern, Bremgartenstrasse 117, 3001 Bern | |
| G7 | Fulminant Ulcerative Colitis initially presenting as Bullous Pyoderma Gangrenosum: a case report and review of literature Joseff Karl Fernandez (1), Ira Yu (1) (1) National Kidney and Transplant Institute; Philippines | |
| G8 | Endoscopic full-thickness resection (FTRD) of a non-ampullary lesions of the proximal duodenum in a 67 year old patient with attenuated polyposis coli Breidert Matthias (1), Anliker Oliver (1), Töpfer Antonia (2), Tajasev Vitali (1), Sieweke Wolfram (1) (1)Dept. of Gastroenterology/Hepatology, City Hospital Waid and Triemli, Location Waid, 8037 Zürich (2)Institute of Pathology, University of Zürich, 8091 Zürich | |
| G9 | Ustekinumab (UST) Induced Clinically Meaningful Improvement and Remission as Measured by the Inflammatory Bowel Disease Questionnaire (IBDQ) in Patients with Moderate to Severe Ulcerative Colitis Colleen Marano(1), Bruce E Sands(2), Chenglong Han(3), Hongyan Zhang(1), Jewel Johanns(1), Philippe Szapary(1), Rupert W Leong(4), Silvio Danese(5) (1)Janssen R&D, Spring House, USA; (2)Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, USA; (3)Janssen Global Services, Malvern, USA; (4)Concord and Macquarie University Hospitals, Sydney, Australia; (5)Humanitas Research Hospital, Milano, Italy | |
| G10 | Effects of Ustekinumab (UST) Induction Therapy on Endoscopic and Histologic Healing in Ulcerative Colitis Colleen Marano(1), Katherine Li(1), Joshua R Friedman(1), Hongyan Zhang(1), Feifei Yang(1), Brian G Feagan(2), Laurent Peyrin-Biroulet(3), Gert De Hertogh(4) (1)Janssen R&D, Spring House, USA; (2)Robarts Clinical Trials, Robarts Research Institute, Western University, London, Ontario, CA; (3)Nancy University Hospital, Université de Lorraine, Nancy, FR; (4)University Hospitals KU Leuven, BE | |
| G11 | Efficacy and Safety of Ustekinumab Through Week 16 in Patients with Moderate to Severe Ulcerative Colitis Colleen Marano(1), Silvio Danese(2), Bruce E Sands(3), Christopher D O’Brien(1), Hongyan Zhang(1), Jewel Johanns(1), Sheldon Sloan(1), James Izanec(1), Philippe Szapary(1), Rupert Leong(4), David Rowbotham(5), Stephan Targan(6), Gert Van Assche(7) (1)Janssen R&D, USA; (2)Humanitas Research Hospital, IT; (3)Icahn School of Medicine, USA; (4)Concord and Macquarie University (U) Hospitals, AU; (5)Auckland City Hospital, NZ; (6)Cedars Sinai Medical Center, USA; (7)U of Leuven, BE | |
| G12 | Efficacy of Ustekinumab (UST) in Moderate-Severe Ulcerative Colitis (UC) in Biologic Failure (BF) and Nonbiologic-Failure (NBF) Populations C. Marano(1), B.E. Sands(2), L. Peyrin-Biroulet(3), C.D. O’Brien(1), H. Zhang(1), J. Johanns(1), P. Szapary(1), D. Rowbotham(4), R.W. Leong(5), R.P. Arasaradnam(6), S. Danese(7), G. van Assche(8), S. Targan (9), W.J. Sandborn(10) (1)Janssen R&D, USA; (2)Icahn School of Medicine at Mount Sinai, USA; (3)Nancy University (U) Hospital, FR; (4)Auckland City Hospital, NZ; (5)The U of New South Wales and Macquarie U, AU; (6)Warwick Medical School, UK; (7)Humanitas Research Hospital, IT; (8)U of Leuven, BE; (9)Cedars Sinai Medical Center, USA; (10)U of California San Diego, USA | |
| G13 | Efficacy and Safety of Ustekinumab (UST) as Maintenance Therapy in Ulcerative Colitis: Week 44 Results from UNIFI C. Marano(1), W.J. Sandborn(2), B.E. Sands(3), R. Panaccione(4), C.D. O’Brien(1), H. Zhang(1), J. Johanns(1), L. Peyrin-Biroulet(5), G. van Assche(6), S. Danese(7), S. Targan(8), M.T. Abreu(9), T. Hisamatsu(10), P. Szapary(1) (1)Janssen R&D, Spring House; (2)University (U) of California San Diego, La Jolla; (3)Icahn School of Medicine at Mount Sinai, New York; (4)U of Calgary, Calgary; (5)Nancy U Hospital, Nancy; (6)U of Leuven, Louvain; (7)Humanitas Research Hospital, Milan; (8)Cedars Sinai Medical Center, Los Angeles; (9)U of Miami Miller School of Medicine, Miami; (10)Kyorin U, Tokyo | |
| G14 | First experiences with ESD + in a 3 cm rectal polyp. A case study at the Stadtspital Waid, Zurich Breidert M, Tajasev V, Locher R, Zellweger M Stadtspital Waid | |
| G15 | Prospective Study of Risk Score Strategies in the Prediction of Advanced Colorectal Neoplasia at Colonoscopy Bianca So (1) Yunki Yau (1, 2) Viraj Kariyawasam (1, 2) Rupert W. Leong (1, 2, 3) (1) Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia (2) Gastroenterology and Liver Services, Concord Repatriation General Hospital, Sydney, NSW, Australia (3) Sydney Medical School, University of Sydney, Sydney, NSW, Australia | |
| G16 | Oeso-mediastinal fistula complicating tuberculosis and cervical lymp node involvement S.Guglielmi(1), G.Guglielmi(2), S.Mönig(3), J-P Janssen(4), L.Spahr(1). 1:Gastroenterolology, 2:Radiology, 3:Visceral Surgery, 4:Pneumology, HUG Hôpitaux Universitaires de Genève | |
| G17 | Phytobezoar causing gastric outlet obstruction as a late complication after biliopancreatic diversion with duodenal switch Simone Zwicky (1,4), Urs Pfefferkorn (1,2,4), Werner Inauen (3,4,5) (1)Department of Surgery, Bürgerspital Solothurn, (2)Department of Surgery, Kantonsspital Olten (3)Clinic for Gastroenterology and Hepatology, Bürgerspital Solothurn (4)Solothurner Spitäler AG, Switzerland (5)University of Bern, Switzerland | |
| G18 | VIDEO - Endoscopic intra-abdominal rescue therapy of a dislodged EUS-guided hepaticogastrostomy stent Johannes Maubach, Andrew J. Macpherson Department of Visceral Surgery and Medicine, University Clinic of Bern, Inselspital, Bern | |
| G19 | VIDEO - Endoscopic rescue therapy of a distally perforated, retroperitoneal stent after EUS-guided pancreaticogastrostomy Johannes Maubach, Andrew J. Macpherson Department of Visceral Surgery and Medicine, University Clinic of Bern, Inselspital, Bern | |
| G20 | Microbial and Metabolic Profile of Longitudinally Sampled Colorectal Cancer Patients Bahtiyar Yilmaz (1,2), Deborah Morgenthalers(1,2), Ruben Mars(3), Lukas Brügger(2), Andreas Kohler(2), Uwe Sauer(3), Andrew J. Macpherson(1,2), and Peter Studer(2) (1) Department for Biomedical Research (DBMR), University of Bern, Bern, Switzerland (2) Uni. Hospital Visceral Surgery and Medicine, Inselspital Bern, Bern, Switzerland (3)Swiss Federal Institute of Technology (ETH) Zürich, Zürich, Switzerland | |
| G21 | Healing earth is an effective therapeutic option in patients with NERD Thomas Orth (1), Hubert Mönnikes (2) (1) Gesundheitszentrum Orth & Orth, Eltville, Germany; (2) Klinik für Innere Medizin, Martin-Luther-Krankenhaus, Berlin, Germany | |
| G22 | EUS-guided hepaticogastrostomy (HGS) with transgastric cholangioscopy (tPOCS) and metal stent insertion for a distal common bile duct (CBD) stenosis in a patient with chronic pancreatitis Hans Entzian, Andrew J. Macpherson, Mathias Worni, Johannes Maubach Department of Visceral Surgery and Medicine, University Clinic of Bern, Inselspital, Bern | |
| G23 | An Unusual Subepithelial Tumor of Duodenum Mentor Bilali 1,2, Bernhard Morell 1,2, Matteo Montani 3, Kaspar Truninger 2, Christoph Gubler 1,2 1 Division of Gastroenterology & Hepatology, University Hospital Zurich, Zurich, Switzerland 2 Division of Gastroenterology, Regional Hospital of Oberaa 1 Division of Gastroenterology & Hepatology, University Hospital Zurich, Zurich, Switzerland 2 Division of Gastroenterology, Regional Hospital of Oberaargau SRO, Langenthal, Switzerland | |
| G24 | Endoscopic control interferes with EndoFLIP measurements Amanda Bianca(1), Valeria Schindler(1,2), Larissa Schnurre(1), Fritz Murray(1), Daniel Runggaldier(3), Daniel Pohl(1) (1) Division of Gastroenterology and Hepatology, University Hospital Zurich, Switzerland. (2) Division of Internal Medicine, Stadtspital Triemli, Zurich, Switzerland. (3) Department of Otorhinolaryngology, University Hospital of Zurich, Switzerland | |
| G25 | Association between histological indices and ulcerative colitis (UC) activity measures among patients in the HICKORY (etrolizumab) open-label induction cohort F. Seibold (1), L. Peyrin-Biroulet (2), B. Feagan (3), R.K. Pai (4), A. Boruvka (5), Y.S. Oh (6), A. Scherl (6), A. Scalori (7), P. Arrisi (8), S. Tole (6), D. T. Rubin (9) (1) Crohn-Colitis Zentrum, Bern and Fribourg, Switzerland; (2) Université de Lorraine, France; (3) University of Western Ontario, Canada; (4) Mayo Clinic Phoenix, USA; (5) Roche Pharma Mississauga, Canada; (6) Genentech, Inc., South San Francisco, USA; (7) Roche Products Limited, Welwyn Garden City, UK; (8) F. Hoffmann-La Roche AG, Basel, Switzerland; (9) University of Chicago Medicine, IL, USA | |
| G26 | Malignant granular cell tumor (GCT) in the oesophagus - rare and difficult to diagnose Dominic Staudenmann1, Rupert Langer2, Yara Banz2, Andrew Macpherson1, Ives Borbély1, Reiner Wiest1 1 Department of Visceral Surgery and Medicine, University Clinic of Bern, 2 Institute of Pathology, University Hospital, Bern | |
| G27 | Endoscopic submucosal dissection and unroofing of a symptomatic antral duplication cyst. A case-report. Ansgar Deibel, Frans Oliver The, Christoph Gubler, Simon Bütikofer Department of Gastroenterology and Hepatology, University Hospital Zurich | |
| G28 | Endobiliary Radiofrequency Ablation (ELRA) for Malignant Billiary Obstruction over 24 months follow-up Stefan H. Schlosser Adrian Casty Peter Netzer Gastrozentrum Netzer and Lindenhof-Spital, Bern | |
| G29 | Diagnosis of Gastric Cancer in the Excluded Stomach after Roux-en-Y Gastric Bypass by Jejunogastrostomy Luca Schneider(1), Arne Kröger(1), Christoph Gubler(2), Frans O. The(2) (1)Department of Internal Medicine, See-Spital, Horgen, Switzerland (2)Department of Gastroenterology and Hepatology, University Hospital Zurich, Switzerland | |
| G30 | Rescue EUS-guided gastro-pancreaticogastrostomy after failed transgastric ERP in a patient with obstructive chronic pancreatitis in the pancreatic head Davide Lanza, Andrew Macpherson, Mathias Worni, Johannes Maubach Department of Visceral Surgery and Medicine, University Clinic of Bern, Inselspital, Bern | |
| G31 | Endoscopic ultrasound-directed transgastric ERCP (EDGE) in a patient with choledocholithiasis after Roux-en-Y gastric bypass (RYGB) and inadvertently interposed colon Thrasyvoulos Gkrezios, Stephan Christen, Andrew J. Macpherson, Mathias Worni, Johannes Maubach Gastroenterology, Clinic for Visceral Surgery and Medicine, University Hospital of Bern, Inselspital, Bern | |
| G32 | HyperCkemia in IBD patients is TNF class-independent Manuel Sutter1,2, Petr Hruz1, Jan Hendrik Niess1,2 1Department of Biomedicine, University Hospital Basel, University of Basel, Switzerland 2University Center for Gastrointestinal and Liver Diseases, St. Clara Hospital and University Hospital, Basel, Switzerland | |
| G33 | The Branched-Chain Amino Acid Transporter CD98 Heavy Chain Supports the Development of Colonic Macrophages Philipp Wuggenig1, Berna Kaya1, Hassan Melhem1, Korcan Ayata1, Petr Hruz2, Julien Roux1,3, Jan Hendrik Niess1,2 1Department of Biomedicine, University Hospital Basel, University of Basel, Switzerland. 2University Center for Gastrointestinal and Liver Diseases, St. Clara Hospital and University Hospital, Basel, Switzerland. 3Swiss Institute of Bioinformatics, Basel, Switzerland | |
| G34 | Sloughing oesophagitis: a rare histologic and endoscopic finding Riad Sarraj (1), Andrew J. Macpherson (1), Marion Bionda (1) (1) Gastroenterology, Clinical for Visceral Surgery and Medicine, Bern University Hospital – Inselspital -, Bern | |
| G35 | Endoscopic ultra-sonography guided drainage of the main pancreatic duct: a Swiss multi-center experience. Sébastien Godat1*, Grégoire David1*, Robert Maxime1, Stefan Christen2, Johannes Maubach2. 1 Division of Gastroenterology and Hepatology, CHUV, Lausanne University Hospital 2 Division of Gastroenterology and Hepatology, Inselspital, Bern | |
| G36 | First experience of gastric peroral endoscopic pyloromyotomy (GPOEM) in a Swiss university endoscopic unit. Eleni Moschouri(1), Grégoire David(1), Maxime Robert(1), Sébastien Godat(1) (1 Service de gastro-entérologie et d’hépatologie, Centre hospitalier universitaire vaudois, Lausanne) | |
| G37 | Amebic liver abscess after first infusion of ustekinumab in a patient with colonic Crohn`s disease manifestation Florian Rybinski1, Maja Weisser2, Jan Hendrik Niess1,Petr Hruz1 1Division of Gastroenterology & Hepatology, Clarunis, Basel, Switzerland 2Division of Infectious Diseases, University Hospital, Basel, Switzerland | |
| G38 | Disease activity in patients with inflammatory bowel disease correlates with the serum copper/zinc ratio Tobias Schneider (1), Daniel Caviezel (1), C. Korcan Ayata (1), Caroline Kiss (2), Jan Hendrik Niess (1), Petr Hruz (1) (1) Division of Gastroenterology & Hepatology, Clarunis, Basel, Switzerland (2) Division of Dietetics and Nutrition, University Hospital Basel, Switzerland | |
| G39 | Endoscopic removal of multiple ingested batteries using a strong magnet Werner Inauen (1,2), Bruno Loosli (1), Felix Brunner (1), Sandra Capraru (1), Brindusa Diaconu (1), Markus Herzig (1), Michaela Neagu (1), Radu Tutuian (1,2,3) (1) Clinic for Gastroenterology and Hepatology, Bürgerspital Solothurn, Solothurner Spitäler AG, Switzerland (2) University of Bern, Switzerland (3) University of Zurich, Switzerland | |
| G40 | Endoscopic treatment of large esophageal leaks Mariola Marx1*, Maxime Robert 1*, Grégoire David1, Sébastien Godat1 1 Division of Gastroenterology and Hepatology, Lausanne University Hospital Division of Gastroenterology and Hepatology, Lausanne University Hospital | |
| G41 | Spontaneus intramural esophageal dissection (IOD): a case report Patrik Dolliana, Henriette Heinrich, Peter Bauerfeind Department of Gastroenterology Stadtspital Triemli, Zurich | |
| G42 | Chenodeoxycholic-acid induced vascular endothelial cell activation: effects on VE-cadherin and endothelial permea-bility S. Vukovic(1), R. Sfriso(1), M. Sorribas(1), R. Rieben(1),R. Wiest(1,2) 1Department for Biomedical Research, University of Bern, 2Department of Visceral Surgery & Medicine, Bern University Hospital, Bern, Switzerland. | |
| G43 | Colon Modeling Open Source Tool (CMOST) for modeling of the natural history of colorectal cancer (1) Benjamin Misselwitz (2) Ansgar Deibel (1) Inselspital Bern (2) UniversitätsSpital Zürich | |
| G44 | Close follow-up is associated with fewer stricture formation and results in earlier detection of histological relapse in the long-term management of eosinophilic esophagitis Thomas Greuter (1), Ekaterina Safroneeva (2), Christian Bussmann (3), Michael Donovan (4), Luc Biedermann (1), Alain M. Schoepfer (5), Talaya McCright-Gill (4), Gabriela N. Mendoza (4), Alex Straumann (1) and Mirna Chehade (4) 1 University Hospital Zurich; 2 University of Bern; 3 Pathology Viollier AG, Basel; 4 Icahn School of Medicine at Mount Sinai, New York, United States of America; 5 University Hospital Lausanne – (CHUV) | |
Hepatology
| H1 | Upper gastrointestinal ulcerations with granulomatous hepatitis and bilateral adrenal masses after Thailand travelling Mikael Sawatzki (1), Christina Lins (2), Christian Bucher (3), Philipp Kohler (4) 1 Division of Gastroenterology/Hepatology, Kantonsspital St.Gallen, St.Gallen, Switzerland 2 Department of Internal Medicine, Spital Rorschach, Rorschach, Switzerland 3 Division of Nephrology, Kantonsspital St.Gallen, St.Gallen, Switzerland 4 Division of Infectious Diseases, Kantonsspital St.Gallen, St.Gallen, Switzerland | |
| H2 | Usefulness of contrast-enhanced ultrasound evaluating focal steatosis in the liver of cystic fibrosis – A case report in a cirrhotic and non-cirrhotic liver – Video Session Mikael Sawatzki (1), David Semela (1), Martin Brutsche (2) 1 Division of Gastroenterology/Hepatology, Kantonsspital St. Gallen, Switzerland 2 Department of Pneumology, Kantonsspital St. Gallen, Switzerland | |
| H3 | Illustrations to support patient counseling before and after liver transplantation Patrizia Künzler-Heule(1), Andrea Pfister-Koch(2), Irina Bergamin(1), Sonja Beckmann(3) (1) Clinic for Gastroenterology/Hepatology, Cantonal Hospital St. Gallen, St. Gallen; (2) Department of Abdomen and Metabolism and (3) Zentrum für Klinische Pflegewissenschaft, University Hospital Zurich, Zurich | |
| H4 | Regulation of lymphangiogenesis by Paneth cells in normal physiology and experimental portal hypertension Mohsin Hassan(1), Andrea De Gottardi (1, 2) , Sheida Moghadamrad (1, 2) 1)Department of Biomedical Research, Hepatology, University of Bern 2)Department of Visceral Surgery and Medicine, Inselspital, University Hospital of Bern, Switzerland | |
| H5 | Quality of life measurement using wrist actigraphy in HCV genotype 1 infected, treatment naïve patients suffering from fatigue and receiving ombitasvir, paritaprevir, and ritonavir tablets and dasabuvir tablets (Viekirax®/Exviera®; 3D regimen): The HEMATI Nasser Semmo(1), Beat Müllhaupt(2), Lisa Ruckstuhl(3), Lorenzo Magenta(4), Olivier Clerc(5), Ralph Torgler(3), David Semela(6) (1) Hepatology, Department of BioMedical Research, University of Bern, Bern, CH. (2) Division of Gastroenterology and Hepatology, University Hospital Zürich, Zürich, CH. (3) AbbVie Schweiz AG, Baar, CH. (4) Epatocentro Ticino, Lugano, CH. (5) Infectious Diseases Department, Hospital Pourtalès, Neuchâtel, CH. (6) Division of Gastroenterology, Kantonsspital St. Gallen, St. Gallen, CH | |
| H6 | Early outcome in patients with non-alcoholic fatty liver in comparison with non-alcoholic steatohepatitis undergoing gastric bypass: a propensity score matched analysis Z. Abbassi, SD Sgardello, S. Naiken, N. Niclauss, M. Chevallay, J. Meyer, SP. Mönig, C. Toso, ME. Hagen, MK Jung University Hospital of Geneva and medical School | |
| H7 | A buyers’ club to improve access to hepatitis C and HIV treatment for vulnerable populations Vernaz Nathalie (1,2), Calmy Alexandra (3), Hurst Samia (4), Jackson Yves (5), Negro Francesco (6), Perrier Arnaud1, Anne-Claire Bréchet (7), Laurent Gétaz (7), Wolff Hans (7) (1) Medical Direction, (2) Finance Direction, (3) HIV Unit, (3) Infectious Disease division, (4) Institute for Ethics, (4) History, and the Humanities, (5) Division of primary care medicine, (6) Divisions of Gastroenterology and Hepatology and of Clinical Pathology, (7) Division of Prison Health, Geneva University Hospitals, University of Geneva, Switzerland | |
| H8 | Evaluation of the prognostic value of histologic parameters in severe alcoholic hepatitis Margaux Dubois (1), Amedeo Sciarra (2), Astrid Marot (3), Christine Sempoux (4), Pierre Deltenre (4,5) (1) Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland (2) Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland (3) Department of Gastroenterology and Hepatology, CHU UCL Namur, Université Catholique de Louvain, Yvoir, Belgium (4) Department of Gastroenterology, Hepatopancreatology, and Digestive Oncology, C.U.B. Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium (5) Department of Gastroenterology and Hepatology, Clinique St Luc, Bouge, Belgium | |
| H9 | Robust MAIT cell activation in response to interactions with primary human liver cell subsets Martin J. Lett(1), Adrian Keogh(2), Tina Jaeger(1), Marie-Anne Meyer(3,4), Isabel Fofana(3), Markus H. Heim(3,4), Deborah Stroka(2), Magdalena Filipowicz Sinnreich(1,5) (1)Liver Immunology, Department of Biomedicine, University Hospital Basel and University Basel, (2)Clinic of Visceral Surgery and Medicine, Department of Clinical Research, University Hospital Bern, (3)Hepatology, Department of Biomedicine, Basel, (4)Gastroenterology and Hepatology, University Hospital Basel, (5)Gastroenterology and Hepatology, Basel University Medical Clinic, Liestal | |
| H10 | Hepatic gene expression analysis identifies marked différences in acute alcoholic microvesicular steatosis compared to alcoholic steatohepatitis (ASH) Nicolas Goossens (1), Laura Rubbia-Brandt(2), Nicolas Lanthier(3), Laurent Spahr(1) (1) Gastroenterology and Hepatology, HUG; (2) Clinical Pathology,HUG;(3) Hepatology, ULB Bruxelles | |
| H11 | Loss of Claudin-3 Results in Metabolic Reprogramming and Impaired Regeneration in the Murine Liver Felix A. Baier(1), Daniel Sánchez-Taltavull(1), Fadi Jebbawi(1), Nicolas Melin(1), Adrian Keogh(1), Ramesh Kudira(1), Mariana Dias(2), Urban Deutsch(2), Mikio Furuse(3), Guido Beldi(1), Britta Engelhardt(2), Daniel Candinas(1), Deborah Stroka(1) (1) Visceral Surgery and Medicine, Department of Biomedical Research, University of Bern and Inselspital Bern, Switzerland (2) Immunobiology Research group, Theodor Kocher Institute Bern (3) Division of Cell Structure, National Institute for Physiological Sciences, Japan | |
| H12 | Thrombin generation in patients with liver cirrhosis: modern global hemostasis assays provide new insights into a procoagulant state Maxime G. Zermatten (1), Montserrat Fraga (2), Debora Bertaggia Calderara (1), Alessandro Aliotta (1), Darius Moradpour (2), Lorenzo Alberio (1) (1) Division and Central Laboratory of Hematology as well as (2) Division of Gastroenterology and Hepatology, Lausanne University Hospital (CHUV), Lausanne, Switzerland | |
| H13 | What if increased INR and aPTT would represent a thrombotic instead of a bleeding risk in cirrhotic patients? Maxime G. Zermatten (1), Montserrat Fraga (2), Debora Bertaggia Calderara (1), Alessandro Aliotta (1), Darius Moradpour (2), Lorenzo Alberio (1) (1) Division and Central Laboratory of Hematology as well as (2) Division of Gastroenterology and Hepatology, Lausanne University Hospital, Lausanne, Switzerland | |
| H14 | Out of Africa: Hepatitis C Virus Subtype 4r as Troublemaker Sophie Cottagnoud(1), Adeline Mathieu(1), Matthieu Perreau(2), Darius Moradpour(1) and Montserrat Fraga(1) (1)Service of Gastroenterology and Hepatology as well as (2)Service of Immunology and Allergy, CHUV, University of Lausanne | |
| H15 | AXL-expressing immune-homeostatic liver macrophages disappear in progressive cirrhosis Oltin T Pop(1,2)*, Robert G Brenig(1,3)*, Evangelos Triantafyllou(4,5), Patrizia Künzler(1), Stephan Brand(1), Julia A Wendon(4), Markus H Heim(3), David Semela(1), Charalambos G Antoniades(4,5), Luigi M Terracciano(6), Christine Bernsmeier(1,3) (1)Gastroenterology&Hepatology,Cantonal Hospital,St.Gallen, (2)Institute of Immunobiology,Cantonal Hospital St. Gallen,(3)Gastroenterology&Hepatology,University Hospital,Basel,(4)King’s College London,UK,(5) Imperial College London,UK, (6)Pathology,University Hospital,Basel;(*contributed equally) | |
| H16 | Autoimmune Idiopathic Disorders in HCV patients: Effect of Direct Antiviral Agents - the AIDAA study (SASL 42) Giuseppe Murgia1, Annalisa Berzigotti1, Benedetta Terziroli2 Adriana Baserga3, David Semela4, Guido Stirnimann1 1Hepatologie, UVCM, Inselspital, Bern; 2Epatocentro Ticino, Lugano; 3Fondazione Epatocentro Ticino, Lugano; 4Klinik für Gastroenterologie/Hepatologie, Kantonsspital St. Gallen | |
| H17 | ABCB4 deficiency associated Copper Overload mimicking Wilson’s disease: a Case report Matthias C. Reichert(1), Vincent Zimmer(1), Frank Grünhage(1), Frank Lammert(1) and Christoph Jüngst (1,2) (1)Department of Medicine II, Saarland University Medical Center, Homburg, Germany, (2)Department of Gastroenterology and Hepatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland | |
| H18 | Targeting the mitotic spindle assembly in patient-derived liver cancer organoids Marie-Anne Meier (1,2), Sandro Nuciforo (1), Lauriane Blukacz (1), Xueya Wang (1), Sylvia Ketterer (1), Stefan Wieland (1), Markus Heim (1,2) (1) Department of Biomedicine, University of Basel, Basel, Switzerland (2) Clarunis – Universitäres Bauchzentrum, Department of Gastroenterology and Hepatology, University Hospital of Basel, Basel, Switzerland | |
| H19 | Liver disease following bone marrow transplantation : clinical and biological characteristics of sinusoidal obstruction syndrome (SOS) and graft-versus-host disease (GVH) Ph.Mathys(1), N.Goossens (1), Y.Chalandon (2), L.Rubbia-Brandt (3), L.Spahr (1) (1) Gastroenterology/Hepatology, (2) Oncohematology, (3) Clinical Pathology, Hôpitaux Universitaires de Genève (HUG) | |
| H20 | Preliminary report on the Swiss Autoimmune Hepatitis Cohort Study Emmanuela Pareti (1) Giacomo Maria Cioffi (2) Andreas Cerny (3) Stefania Casu (4) Christiane Sokollik (5) Christian Braegger (6) David Semela (7) Giorgina Mieli-Vergani (8) Diego Vergani (9) Benedetta Terziroli Beretta-Piccoli (3,9) (1) Internal Medicine; Ospedale Beata vergine; Mendrisio; Switzerland (2) Cardiology Divison; Fondazione Cardiocentro Ticino; Lugano; Switzerland (3) Hepatology Department; Epatocentro Ticino; Lugano; Switzerland (4) Pankreas Zentrum; Inselspital; Bern; Switzerland (5) Pediatric gastroenterology; Hepatology and Nutrition Department; Inselspital; Bern; Switzerland (6) Gastroenterologie und Ernährung; Universitäts-Kinderspital; Zurich; Switzerland (7) Gastroenterologie und Hepatologie; Kantosspital St. Gallen; St. Gallen; Switzerland (8) Paediatric Liver, GI and Nutrition Centre; MowatLabs, King's College Hospital; London; UK (9) Institute of Liver Studies; MowatLabs, King's College Hospital; London; UK | |
| H21 | Preliminary report on the Swiss Primary Biliary Cholangitis Cohort Study Emmanuela Pareti (1) Giacomo Maria Cioffi (2) Andreas Cerny (3) Guido Stirnimann (4) Magdalena Filipowicz (5) Joachim Mertens (6) David Semela (7) Adriana Baserga (3) Stefano Bellentani (8) Benedetta Terziroli Beretta-Piccoli (3,9) (1) Internal Medicine; Ospedale Beata vergine; Mendrisio; Switzerland (2) Cardiology Divison; Fondazione Cardiocentro Ticino; Lugano; Switzerland (3) Hepatology Department; Epatocentro Ticino; Lugano; Switzerland (4) Leberzentrum; Inselspital; Bern; Switzerland (5) Department Biomedizin, Kantonsspital Baselland, Liestal; Switzerland (6) Klinik für Gastroenterologie und Hepatologie, Universitätsspital; Zurich; Switzerland (7) Gastroenterologie und Hepatologie; Kantosspital St. Gallen; St. Gallen; Switzerland (8) Clinica Santa Chiara, Locarno; Switzerland (9) Institute of Liver Studies; MowatLabs, King's College Hospital; London; UK | |
| H22 | Epidemiology of hepatocellular carcinoma linked to non-alcoholic fatty liver disease in the canton of Geneva between 1990-2014: a populational and prospective study Myers S (1), Gkouvatsos G (2), Spahr L (2), Giostra E (2), Bascaron ME (2), Frossard JL (2), Fournier E (3), Neyroud I (3), Goossens N (1, 2). (1) Faculty of Medicine, (3) Geneva Cancer Registry, University of Geneva. (2) Division of Gastroenterology and Hepatology, Geneva University Hospital | |
| H23 | The gene signature-MELD score and alcohol consumption determine long-term prognosis of patients with severe alcoholic hepatitis Pierre Deltenre1,2,3, Eric Trépo1,4, Naoto Fujiwara5, Nicolas Goossens5,6, Astrid Marot3,7, Margaux Dubois8, Laurent Spahr6, Jean Henrion4, Christophe Moreno1,4, Yujin Hoshida5 1Department of Gastroenterology, Hepatopancreatology, and Digestive Oncology, C.U.B. Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium. 2Department of Gastroenterology and Hepatology, Clinique St Luc, Bouge, Belgium 3Department of Gastroenterology and Hepatology, Hôpital de Jolimont, Haine-Saint-Paul, Belgium 4Laboratory of Experimental Gastroenterology, Université Libre de Bruxelles, Brussels, Belgium. 5Division of Digestive and Liver Diseases. Department of Internal Medicine. University of Texas Southwestern Medical Center, Dallas, USA. 6Division of Gastroenterology and Hepatology, Geneva University Hospital, Geneva, Switzerland. 7Department of Gastroenterology and Hepatology, CHU UCL Namur, Université Catholique de Louvain, Yvoir, Belgium 8Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland. | |
| H24 | Video Case - „Unusual presentation of recurrent, large and symptomatic focal nodular hyperplasia of the liver“ Pamela Meyer-Herbon1, Daniela Husarik2, Jörg Neuweiler3, Bruno Schmied4, David Semela1 1Department of Gastroenterology and Hepatology, Kantonsspital St. Gallen 2Department of Radiology and Nuclear Medicine, Kantonsspital St. Gallen 3Institute of Pathology, Kantonsspital St. Gallen 4Department of General and Visceral Surgery, Kantonsspital St. Gallen | |
| H25 | Insulin resistance in Hepatitis C virus infection: Relative contribution from liver vs. extrahepatic sites Diana Gomes (1)§, Giacomo Gastaldi (2)§, Philippe Schneiter (3), Xavier Montet (4), Luc Tappy (3), Cyril Sobolewski (4), Nicolas Goossens (5), Michelangelo Foti (4), Sophie Clément (6)*, and Francesco Negro (5, 6)* §*equal contribution (1) Dpt of Pathology and Immunology, and (4) Cell Physiology and Metabolism, UNIGE; (3) Dpt of Physiology, UNIL, (2) Divisions of Endocrinology, (4) radiology, (5) Gastroenterology and Hepatology, and (6) Clinical Pathology, HUG | |
| H26 | Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies Dulce Alfaiate (1), Sophie Clément (2), Diana Gomes (1), Nicolas Goossens (3) and Francesco Negro (2, 3) (1) Dpt of Pathology and Immunology, University of Geneva, (2) Division of Clinical Pathology, (3) Division of Gastroenterology and Hepatology, Geneva University Hospitals | |
| H27 | Global real world evidence of sofosbuvir/velpatasvir as a simple, effective regimen for the treatment of chronic hepatitis C patients: Integrated Analysis of 12 clinical practice cohorts Alessandra Mangia(1); Scott Milligan(2); Mandana Khalili(3); Stefano Fagiuoli(4); Stephen D Shafran(5); Fabrice Carrat (6); Denis Ouzan(7); George Papatheodoridis(8); Alnoor Ramji(9); Sergio M Borgia(10); Heiner Wedemeyer(11); Losappio(1); Francisco Pérez (1)Ospedale Casa Sollievo Della Sofferenza, San Giovanni Rotondo, ITALY. (2)Trio Health Analytics, La Jolla, CA, USA. (3)University of California San Francisco/San Francisco General Hospital, CA, USA. (4)Asst Papa Giovanni XXIII, Italy - Lombardia HCV Network (5)University of Alberta, Canada. (6)Sorbonne Université, Institut National de la santé et de la Recherche Médicale, Institut Pierre Louis d’Epidémiologie et de Santé Publique, Paris ; Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, Unité de Santé Publique, Paris, France & ANRS CO22 HEPATHER France. (7)Institut Arnault Tzanck, Saint-Laurent du Var, France. (8)Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, Laiko General Hospital of Athens, Greece. (9)University of British Columbia, Canada. (10)Infectious Diseases, William Osler Health System, Brampton, Ontario, Canada. (11)Leberstiftungs-GmbH Deutschland, Hannover, Germany; Department of Gastroenterology and Hepatology, Essen University Hospital, Germany. (12)Hospital Universitario NS Candelaria, Tenerife, Spain – HEPA-C Cohort. (13)Medstar Health Research Institute, Washington DC, USA. (14)CRC “A. M. and A. Migliavacca” Center for the Study of Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy. (15)St Vincent’s Hospital, Melbourne, Australia. (16)Medical Affairs, Gilead Sciences, Switzerland. (17)Medical Affairs, Gilead Sciences, Australia. (18)Medical Affairs, Gilead Sciences Europe Ltd. U.K. (19)Department of Gastroenterology and Hepatology, C.H.U. Pontevedra & IIS Galicia Sur, Spain – HEPA-C cohort. | |
| H28 | A Phase 3 Study Comparing Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide With Continued TDF Treatment in Virologically Suppressed Patients With Chronic Hepatitis B: Week 48 Efficacy and Safety Results Pietro Lampertico(1), Maria Buti(2), Scott Fung(3), Sang Hoon Ahn(4), Wan-Long Chuang(5), Won Young Tak(6), Alnoor Ramji(7), Chi-Yi Chen(8), Edward Tam(9), Ho Bae(10), Xiaoli Ma(11), John F. Flaherty(12), Anuj Gaggar(12), Audrey Lau(12), Becket Feierbach( (1)Universita Degli Studi di Milano, Italy; (2)Hospital Universitari Vall d'Hebron, Barcelona, Spain; (3)Toronto General Hospital, Toronto, Ontario, Canada; (4)Yonsei University, Severance Hospital, Seoul, South Korea; (5) Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan; (6)Kyungpook National University Hospital, Daegu, South Korea; (7)GI Research Institute, Vancouver, British Columbia, Canada; (8)Chia-Yi Christian Hospital, Chia-Yi City, Taiwan; (9)LAIR Centre, Vancouver; (10)Asian Pacific Liver Center, Los Angeles, California, USA; (11)Hahnemann University Hospital, Philadelphia, Pennsylvania, USA; (12)Gilead Sciences, Inc., Foster City, California; (13)Gilead Sciences, Steinhausen, Switzerland; (14)Silicon Valley Research Institute, San Jose, California; (15)The Catholic University of Korea, Seoul; (16)King’s College Hospital, London, UK; (17)Asan Medical Center, Seoul; (18)The Chinese University of Hong Kong, China | |
| H29 | A combination of the ACC inhibitor GS-0976 and the nonsteroidal FXR agonist GS-9674 improves hepatic steatosis, biochemistry, and stiffness in patients with non-alcoholic steatohepatitis Eric Lawitz(1), Edward Gane(2), Peter Ruane(3), Robert Herring, Jr.(4), Ziad H. Younes(5), Paul Kwo(6), Jie Zhang(7), Catherine Jia(7), Jay Chuang(7), Bryan McColgan(7), Chuhan Chung(7), Mani Subramanian(7), Robert Myers(7), Ramon Thali(8), Michael Middl (1)Texas Liver Institute, University of Texas Health San Antonio, San Antonio, United States; (2)Liver Unit, Auckland City Hospital, Auckland, New Zealand; (3)Ruane Clinical Research, Los Angeles, United States; (4)Quality Medical Research, Nashville, United States; (5)GastroOne, Germantown, United States; (6)Stanford University School of Medicine, Palo Alto, United States; (7)Gilead Sciences, Inc., Foster City, United States; (8)Gilead Sciences, Steinhausen, Switzerland; (9)University of California at San Diego, San Diego, United States; (10)University of California Berkeley, Berkeley, United States; (11)Cedars-Sinai Medical Center, Los Angeles, United States; (12)Pinnacle Clinical Research, San Antonio, United States | |
| H30 | LIM Protein Ajuba Promotes Cancer Cell Proliferation and Survival in Hepatocellular Carcinoma Noëlle Dommann (1), Jacopo Gavini (1), Daniel Sánchez-Taltavul (1), Tess Brodie (1), Michaela Medova (2), Magali Humbert (3), Mario Tschan (3), Daniel Candinas (1),Deborah Stroka (1) (1)Visceral Surgery and Medicine, (2)Radiation Oncology, Department of Biomedical Research Bern, (3)Tumor Pathology, Institute of Pathology, University of Bern, CH | |
| H31 | Look-back procedure to reach non-compliant and lost to
follow-up HBV patients S. Costantini*, C. Taiana*, B. Terziroli Beretta-Piccoli, A. Baserga, D. Hagara, A. Cerny, L. Magenta. * SC and CT contributed similarly to this study Epatocentro Ticino, Lugano, Switzerland (all authors) | |
| H32 | Lysosomal compartment dysregulation as a treatment strategy for hepatocellular carcinoma Jacopo Gavini(1), Noëlle Dommann(1), Manuel O. Jakob(1), Adrian Keogh(1), Laure C. Bouchez(4), Sofia Karkampouna(2), Marianna Kruithof-de Julio(2), Michaela Medova(3), Yitzhak Zimmer(3), Daniel Candinas(1), Deborah Stroka(1), Vanessa Banz(1) 1- Department of Visceral Surgery and Medicine, Department for BioMedical Research, Inselspital, Bern University Hospital and University of Bern, 3010 Bern, Switzerland 2- Department of Urology, Department for BioMedical Research, Inselspital, Bern University Hospital and University of Bern, 3010 Bern, Switzerland 3- Department of Radiation Oncology, Department for BioMedical Research, Inselspital, Bern University Hospital and University of Bern, 3010 Bern, Switzerland 4- Glenmark Pharmaceuticals, Lausanne, Switzerland | |
| H33 | Concurrent biliary toxoplasmosis and portal-hypertensive cholangiopathy: a rare cause of haemobilia Francisco Bravo, Johannes Maubach, Reiner Wiest Department of Surgery and Medicine, Bern university Hospital | |
| H34 | REGENERATE: A Phase 3 International, Placebo-Controlled Study Evaluating Obeticholic Acid Treatment for NASH Zobair Younossi1, Vlad Ratziu2, Jean-Francois Dufour3, Leigh MacConell4, Reshma Shringarpure4, Stephen Harrison5, Arun J. Sanyal6 on behalf of the REGENERATE Study Investigators INSELSPITAL University Clinic for Visceral Surgery and Medicine (UVCM)/Hepatology Freiburgstrasse 18, 3010 Bern | |
Surgery
| S1 | Efficiency of an integrated workflow with augmented reality in 3D laparoscopic liver resection: clinical evaluation of a
new image guided surgery system Gian Andrea Prevost (1), Benjamin Eigl (2), Iwan Paolucci (3), Matthias Peterhans (2), Stefan Weber (3), Guido Beldi (1), Daniel Candinas (1), Anja Lachenmayer (1) 1) Department of Visceral Surgery and Medicine, Inselspital, University of Bern, 3010 Bern 2) CAScination AG, Steigerhubelstrasse 3, 3008 Bern 3) ARTORG Center for Biomedical Engineering Research, University of Bern, 3010 Bern | |
| S2 | VIDEO OF A LAPAROSCOPIC REPAIR OF A STRANGULATED OBTURATOR HERNIA Marius Antonescu, Markus Debelic, Romain Schaller Service de Chirurgie, Hôpital du Jura | |
| S3 | Intraductal papillary neoplasia of the bile ducts - a rare diagnosis Stéphanie F. Perrodin, MD, Vanessa Banz, MD-PhD, Prof. Daniel Candinas, Corina Kim-Fuchs, MD-PhD Department of Visceral Surgery and Medicine, University Hospital Bern, Inselspital, 3010 Bern, Switzerland | |
| S4 | Publication of surgery specific outcomes as quality indicator - time to get involved? Raffaele Galli, Robert Rosenberg Klinik für Chirurgie, Kantonsspital Baselland | |
| S5 | Compliance to the Surgical Safety Checklist over time in late and early adopters Romain L. Seppey (1), Antoine Oesch (1), Carsten T. Viehl (1) (1) Department of Surgery, Hospital Center Biel/Bienne, Biel/Bienne, Switzerland | |
| S6 | Laparoscopic treatment of enterolith bowel obstruction: 2 cases report. Delgadillo Xavier (¹) - Ott Vincent (²) - Wuthrich Philippe (³) (¹)Centre Médico Chirurgical Volta, rue de la Paix 152, 2300- La Chaux‑de‑Fonds. (²) Hôpital La Providence, Faubourg de l'Hôpital 81, 2000- Neuchâtel.(³) Clinique de Genolier, Route du Muids 3, 1272- Genolier - Switzerland. | |
| S7 | Laparoscopic Extended Left Hepatectomy for Giant Haemangioma. Technical Strategies for Complex Liver Resection. Lukasz Filip Grochola (1), Erik Schadde (1), Stefan Breitenstein (1) (1) Department of Surgery, Cantonal Hospital Winterthur. | |
| S8 | The other liver metastasis with a crucial impact on the prognosis Marionna Cathomas (1), Paolo Abitabile (2), Rok Dolanc (2), Christine Glaser (2), Gieri Cathomas (3) (1) Chirurgische Klinik, Spital Münsterlingen, Schweiz (2) Chirurgische Klinik, Gesundheitszentrum Fricktal, Rheinfelden und Laufenburg, Schweiz (3) Institut für Pathologie, Kantonsspital Baselland, Liestal, Schweiz | |
| S9 | Colorectal cancer associated with schistosomiasis- a case report Kim, Herzog (1) Matthias, Matter (2) Philippe, Glauser (1) Department of Surgery, Spital Dornach, Switzerland (1) Institute of Pathology, Universitätsspital Basel, Switzerland (2) | |
| S10 | Role of PKM2 in macrophage polarization during liver regeneration. Nicolas Melin, Giulio Loforese, Joel Zindel,, Isabel Büchi, Tess M. Brodi, Daniel Sanchez-Taltavull, Daniel Candinas, Deborah Stroka. Viseral Surgery and Medecine, Department for Biomedical Research, University of Bern | |
| S11 | Robot-assisted gastric GIST resection: a single center experience Wassmer CH1, Chevallay M1, Colucci N1, Buchs NC1, Morel P1, Jung M1, Mönig SP1 1 Visceral and Transplant Surgery, Department of Surgery, University Hospitals of Geneva, and Medical School, Geneva, Switzerland | |